Reimagining kidney care
Fifteen percent of U.S. adults are estimated to have chronic kidney disease (CKD), and recent headlines have highlighted increasing momentum around better kidney care solutions. Last week Healthmap, a kidney population health management company, raised $100M, joining mega deals raised by Strive Health and Monogram Health earlier this year. These large raises for kidney care-focused startups are all the more notable in an otherwise tight funding environment. Additionally, CVS’s Signify Health just announced a new in-home chronic kidney disease testing service as part of its diagnostic and preventative offerings. Heavy hitters DaVita and Medtronic have also recognized the opportunity with the spring launch of joint venture Mozarc Medical, focused on developing at-home kidney care tech.
Inequitable disease burden plagues the kidney care space—Black Americans and individuals facing poverty or food insecurity are at disproportionate risk for developing CKD. And with 20% of Medicare dollars spent on kidney care, there’s a huge need to reduce costs in the space. Startups going after kidney care gaps have the opportunity to improve access, equity, and costs for millions of Americans.
Rock Health Summit 2023 is less than two months away! Check out the latest additions to our speaker lineup—they’ll cover topics including AI in healthcare, health at home innovation, and much more. Prices will increase Friday, August 18th at 11:59pm PST. Register today to learn from and connect with digital health's brightest minds in San Francisco on September 27!
Amazon Adds Video Telemedicine Visits Nationwide To Its Virtual Clinic
Patients can compare prices, response times to select providers; insurance not accepted AP News
With Profitability In Sight, Talkspace Is Budding Into A Digital Health Success Story
B2B pivot to focus on payers is reaping rewards STAT
Gastric Balloon Maker Allurion Pops Health Tech Market Bubble With A SPAC
Guess what’s back…SPAC again Axios
What's Behind Digital Health’s Funding Freefall
Despite headwinds, there's still plenty of potential with mega deals and the buzz around AI Modern Healthcare